Med-IQ Logo
Get CME/CE

Course Listings: Oncology

All Results (15)
Format: Live Events (0) Online Activities (15)

Managing CLL With Targeted Oral Agents: Educating and Empowering Patients to Improve Adherence

View Course

Format: E-publication

    Maximum Credits:
  • 0.5 AMA PRA Category 1 Credit(s)

Course Description: This CME publication addresses the practical considerations of using oral agents in the treatment of chronic lymphocytic leukemia. It reviews strategies for managing adverse events, discusses reasons for medication nonadherence, and offers tips for engaging patients and improving adherence to oral agents.


Advances in Pancreatic Cancer Treatment: Options When First-Line Therapy Fails

View Course

Format: E-publication

    Maximum Credits:
  • 0.75 AMA PRA Category 1 Credit(s)

Course Description: This Web-based CME publication presents contemporary evidence on the use of available treatments in patients with advanced metastatic pancreatic cancer. The biologic importance and potential therapeutic implications of the stromal microenvironment is also explored along with an update on several agents under development for pancreatic cancer.


A New Era in NSCLC: What We’ve Learned and Where We’re Headed

View Course

Format: E-publication

    Maximum Credits:
  • 0.5 AMA PRA Category 1 Credit(s)

Course Description: In this interactive, online publication, clinical guidelines and other evidence are presented to explore evolving approaches to maintenance therapy and continuation versus switch strategies in non–small cell lung cancer (NSCLC). Case studies and expert faculty commentary are included to demonstrate how multiple factors can influence decision making when…More


Earlier Recognition and Treatment of Gaucher’s Disease in Hematology Clinics

View Course

Format: Webcast

    Maximum Credits:
  • 0.75 AMA PRA Category 1 Credit(s)

Course Description: In this CME-certified Webcast, expert medical geneticist Pramod K. Mistry, MD, PhD, FRCP, and hematologist Neal J. Weinreb, MD, discuss approaches to recognize symptoms of Gaucher’s disease (GD) type 1 early in the disease course. They also explore optimal treatment strategies based on clinical evidence, including efficacy and safety data, for patients with…More


Metastatic HER2+ Breast Cancer

View Course

Format: Webcast

    Maximum Credits:
  • 0.5 AMA PRA Category 1 Credit(s)

Course Description: This 30-minute Webcast features two international experts discussing recent clinical evidence regarding the treatment of metastatic HER2+ breast cancer and strategies for incorporating those data into treatment decisions. Faculty also discuss recent guidelines and barriers to optimal patient care within the framework of a dynamic patient case.


Neoadjuvant Therapy for HER2+ Breast Cancer

View Course

Format: Webcast

    Maximum Credits:
  • 0.5 AMA PRA Category 1 Credit(s)

Course Description: This 30-minute Webcast features two international experts discussing recent clinical evidence on the optimal timing of neoadjuvant therapy for the treatment of patients with HER2+ breast cancer. Faculty also provide feedback on challenges faced by clinicians around the globe.


Immunotherapy for Triple-Negative Breast Cancer

View Course

Format: Webcast

    Maximum Credits:
  • 0.5 AMA PRA Category 1 Credit(s)

Course Description: This 30-minute Webcast features two international experts discussing new and emerging therapies for the immunologic treatment of triple-negative breast cancer.


Keeping Up With the Clinicians: Insights in Multiple Myeloma Treatment Strategies in the Frontline and Relapsed/Refractory Settings

View Course

Format: Audiocast

    Maximum Credits:
  • 0.75 AMA PRA Category 1 Credit(s)

Course Description: In this audiocast, our expert faculty discuss the current treatment options available for multiple myeloma and debate the optimal application of various single-agent and combination regimens in the frontline and relapsed/refractory treatment settings.


Medical Insiders: Emerging Science for the Management of Metastatic Castration-Resistant Prostate Cancer

View Course

Format: Webcast

    Maximum Credits:
  • 0.75 AMA PRA Category 1 Credit(s)

Course Description: This conversation-style Webcast discusses how to best incorporate recent guideline recommendations and clinical evidence into the treatment of metastatic castrate-resistant prostate cancer. Case studies are presented to facilitate discussions on treatment choices and sequencing.


Evolving Risk Profiles for Tumor Lysis Syndrome: Aggressive Prophylaxis Strategies to Prevent Adverse Patient Outcomes

View Course

Format: E-publication

    Maximum Credits:
  • 0.5 AMA PRA Category 1 Credit(s)

Course Description: This interactive, case-based publication examines current evidence and available treatment algorithms to assess tumor lysis syndrome (TLS) risk. In addition, it presents recommendations for developing prophylaxis strategies for patient types who historically have not been considered to have an elevated risk of this potentially serious complication. The…More


Clinical Phenotypes of Advanced Prostate Cancer

View Course

Format: Webcast

    Maximum Credits:
  • 0.75 AMA PRA Category 1 Credit(s)

Course Description: In this Webcast, faculty discuss different clinical phenotypes of prostate cancer and explore how those phenotypes can be used to direct decisions regarding risk stratification, prognosis, and treatment of this disease.


Harnessing the Power of the Immune System to Fight Cancer

View Course

Format: E-Publication

    Maximum Credits:
  • 0.5 AMA PRA Category 1 Credit(s)

Course Description: Substantial advances have been made over the past decade related to the role of the immune system in the growth and progression of cancer. This CME-certified publication reviews the rationale for the development of immune checkpoint inhibitors, as well as recent clinical trial evidence for the use of these therapies in the treatment of metastatic melanoma and…More


Optimizing Outcomes in Acute Lymphoblastic Leukemia Treatment: Use of Asparaginase and Supportive Care Challenges

View Course

Format: E-publication

    Maximum Credits:
  • 1.0 AMA PRA Category 1 Credit(s)
  • 1.0 California Board of Registered Nursing (CBRN)

Course Description: This CME/CE publication reviews the role of asparaginase in the treatment of acute lymphoblastic leukemia. It discusses selecting, monitoring, and modifying asparaginase therapy, as well as managing treatment-related toxicities. This activity also includes video clips of expert faculty providing insights in this evolving therapeutic area.


A Focus on EGFR Signaling in Lung Adenocarcinoma

View Course

Format: E-Publication

    Maximum Credits:
  • 0.5 AMA PRA Category 1 Credit(s)

Course Description: This CME publication reviews the role of EGFR signaling in advanced lung adenocarcinoma. It includes a discussion on the rationale for performing EGFR mutation analysis before initiating therapy and explores how the results of the analysis can best be applied to treatment-related decision making.


Improving Outcomes for Patients With CLL: Focus on Targeted Therapies and Quality-of-Life Concerns

Resume Course

Format: E-Publication

    Maximum Credits:
  • 1.0 AMA PRA Category 1 Credit(s)
  • 1.0 Accreditation Council for Pharmacy Education (ACPE)
  • 1.0 American Nurses Credentialing Center (ANCC)

Course Description: This Web-based CE activity includes up-to-date information about targeted therapies for CLL and strategies for individualizing treatment. There is also a comprehensive discussion of quality-of-life issues, including suggestions for identifying and managing issues related to physical, cognitive, and emotional well-being for patients living with CLL.